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Abstract
Background: Gene promoters fused to the firefly luciferase gene (luc) are useful for examining
gene regulation in live transgenic mice and they provide unique views of functioning organs. The
dynamics of gene expression in cells and tissues expressing luciferase can be observed by imaging
this enzyme's bioluminescent oxidation of luciferin. Neural pathways involved in specific behaviors
have been identified by localizing expression of immediate-early genes such as c-fos. A transgenic
mouse line with luc controlled by the human c-fos promoter (fos::luc) has enabled gene expression
imaging in brain slice cultures. To optimize imaging of immediate-early gene expression throughout
intact mice, the present study examined fos::luc mice and a second transgenic mouse containing luc
controlled by the human cytomegalovirus immediate-early gene 1 promoter and enhancer
(CMV::luc). Because skin pigments and hair can significantly scatter light from underlying structures,
the two transgenic lines were crossed with a hairless albino mouse (HRS/J) to explore which deep
structures could be imaged. Furthermore, live anesthetized mice were compared with overdosed
mice.
Results: Bioluminescence imaging of anesthetized mice over several weeks corresponded with
expression patterns in mice imaged rapidly after a lethal overdose. Both fos::luc and CMV::luc mice
showed quantifiable bright bioluminescence in ear, nose, paws, and tail whether they were
anesthetized or overdosed. CMV::luc and fos::luc neonates had bioluminescence patterns similar to
those of adults, although intensity was significantly higher in neonates. CMV::luc mice crossed with
HRS/J mice had high expression in bone, claws, head, pancreas, and skeletal muscle, but less in
extremities than haired CMV::luc mice. Imaging of brain bioluminescence through the neonatal skull
was also practical. By imaging luciferin autofluorescence it was clear that substrate distribution did
not restrict bioluminescence imaging to capillaries after injection. Luciferin treatment and
anesthesia during imaging did not adversely affect circadian rhythms in locomotor activity.
Conclusions: Imaging of gene expression patterns with luciferase can be extended from studies
of live animals to rapid imaging of mice following a pentobarbital overdose before significant effects
from postmortem changes occurs. Bioluminescent transgenic mice crossed with HRS/J mice are
valuable for examining gene expression in deep tissues.
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Background
Several researchers have described how transgenic mice
expressing reporter genes that produce a fluorescent or
bioluminescent product can be imaged continuously to
assay gene expression, image changes in tumor growth, or
follow the progress of infections [1]. Dynamic changes in
gene expression have also been monitored in individual
cells maintained in culture by imaging fluorescent or bioluminescent reporter genes [2–4]. In general, fluorescence
methods are easier to use than those based on bioluminescence and often can be implemented with an existing
camera system and fluorescence microscope. Whole-animal fluorescence imaging is, however, complicated by the
practical limitations of directing excitation light into
organisms, and is limited by the tissue's autofluorescence,
which degrades the signal-to-noise ratio (S/N). Rather
than administering excitation light, bioluminescence
imaging based on firefly luciferase (luc) requires introduction of the enzyme substrate luciferin that reaches target
areas via the blood supply and diffusion. Furthermore,
because bioluminescence signals are nearly absent from
most tissues, the S/N can be much larger than with fluorescence methods based on green fluorescent protein
(GFP), a popular reporter gene product [5].
For most genes, the time course of expression is usually
assayed by harvesting tissue from many animals at multiple time points. In contrast, whole-animal imaging in a
single animal enables much simpler ongoing tracking of
gene regulation involved in time-dependent processes
such as development, growth, circadian rhythms, and disease in individual animals [1,6–13]. By monitoring
responses in the same animal before and after onset of
gene induction, noise from inter-individual variation is
eliminated, and animals are used more efficiently. Furthermore, several treatments can be tested sequentially in
the same animal.
Although live mice provide the benefits of serial imaging,
they can produce movement artifacts in images because of
breathing or twitching. Mice given a lethal overdose of
anesthesia would yield more stable imaging, but postmortem metabolic changes in tissue oxygen or ATP levels
could affect the luciferase reaction, and cell stress can alter
expression of new luciferase. We examined anesthetized
and acutely overdosed mice to test whether the bioluminescence pattern shortly after an overdose remains consistent with the live animal signal.
We compared two lines of transgenic mice containing
luciferase controlled by immediate-early gene promoters
that respond rapidly following a stimulus and produce
large changes in brightness. The luc gene is controlled by
the human c-fos promoter in one line (fos::luc) and by the
human cytomegalovirus immediate-early gene 1 enhancer
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and promoter in the other (CMV::luc) [14]. Both strains
were generated by oocyte injection, so each cell carries the
transgene. The distribution of the protein or mRNA of cfos has been used to localize neuronal excitation, cellular
correlates of behavior, and cell division in many tissues
for over a decade [15–18]. The human CMV promoter/
enhancer responds to signals mediating inflammation
and cell stress [19–21] and was recently shown to be
induced by cell membrane depolarization [22]. Consequently, several tissues of both transgenic mice provide
rapid responses to a broad range of stimulation.
To image gene expression throughout transgenic rodents,
luciferin is typically injected intraperitoneally or by the
tail vein. In either case, it is carried through the circulatory
system and by diffusion. If this charged molecule does not
readily penetrate all areas, the pattern of the luciferase signal could be influenced by the distribution of luciferin.
Although luciferin readily crosses cell membranes, it
might remain primarily within blood vessels, in which
case these structures could dominate images of tissues and
bias accurate interpretation of gene expression patterns.
The intrinsic fluorescence of luciferin was used to image
its distribution in the brain, evaluating whether it easily
passes through some of the least permeable endothelial
cells of the body.
It was also important in this study to determine the range
of gene expression that could be quantified simultaneously in various areas of individual mice, because previous studies often provided images with unstated dynamic
range. Subtle changes in gene expression could be imaged
here even when they occurred above elevated background
expression rather than the completely dark background of
inactive tissue, as shown by logarithmic scaling. Both
transgenic lines were crossed with a hairless, albino
mouse (HRS/J yielding Hr-CMV and Hr-fos) to test
whether internal organs and other deep structures could
be readily visualized in these strains. Repeatable patterns
of expression in specific body areas of hairless mice verified that luciferase bioluminescence imaging of these
mice is a promising approach for long-term quantitative
measurements of gene expression in live animals.

Results
Overdosed mice
Gene expression patterns were characterized using bioluminescence imaging of intact mice. It was necessary to
introduce luciferin into the body so that it could reach all
cells and organs at sufficient concentrations to generate
measurable light. Images of luciferin autofluorescence
suggested that it could readily cross the blood-brain barrier (Fig. 1). The sodium salt of luciferin was administered
intraperitoneally (i.p.) at 10 mM in PBS. A volume of 0.1
ml provided bioluminescence images of the skin, brain,
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Figure 1 of luciferin into brain, skin, and internal organs
Dispersal
Dispersal of luciferin into brain, skin, and internal
organs. Left: Brain slices from thalamic area of adult
CMV::luc mice injected i.p. with luciferin or not injected
(control). Autofluorescence of luciferin in near-UV light
showed that it is distributed diffusely and not restricted to
the capillaries (arrow in brightfield). Right: Bioluminescence
in an overdosed fos::luc neonate (postnatal day 1) imaged for
10 minutes. (A) Dorsal and (B) ventral views of the same
mouse showed transgene expression in paws, tail, ears, nose,
and internal organs of the abdomen. Light from the brain was
visible after first removing skin over the cranium (C) and
then upper cranium itself in (D). Arrows: brain
bioluminescence.

and internal structures in adult CMV::luc and fos::luc mice
after an overdose with pentobarbital (Fig. 1, 2). Likewise,
overdosed neonatal fos::luc mice showed expression in
the brain that was visible through the skull (Fig. 1C) and
was clearer after removal of the dorsal cranium (Fig 1D).
Bioluminescence was detected in all neonates and adults
of the two original transgenic lines during 10-minute
exposures captured immediately after the overdose to
minimize any effects from new luciferase synthesis (Fig. 2,
Table 1). Quantitative comparisons of signal intensity
revealed highest gene expression in the paws, tail, and ears
in both lines, and CMV::luc mice exhibited higher signals
than age matched fos::luc mice. Using whole animal
measurements, CMV::luc neonates were 3-fold brighter
than fos::luc neonates (p < 0.001, analysis of variance
(ANOVA) and Scheffe posthoc test) and 20-fold brighter
than CMV::luc adults (p < 0.001). Fos::luc neonates were
9-fold brighter than fos::luc adults (p < 0.05). CMV::luc
adults were brighter on average than fos::luc adults, but
these differences were not significant. Light was also
detected from around the mouth of neonates and adults
of both lines.
Although neonates were surprisingly similar to adults in
their signal, there were some distinct differences; both
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Figure
Expression
and
fos::luc
2 in
mice
similar body regions of overdosed CMV::luc
Expression in similar body regions of overdosed
CMV::luc and fos::luc mice. (A) CMV::luc neonate showing higher expression than (B) a fos::luc neonate. Both had
highest expression in the paws, tail, ears, and nose, but the
CMV::luc mice also showed a bright signal from a point on
the dorsal surface of the head. Likewise, adult CMV::luc (C)
and fos::luc mice (D) had similar gene expression patterns,
like those of neonates, with a few exceptions. CMV::luc
adults also showed expression through the eyes and fur of
the abdomen (short arrows). (Paws: long arrows.) Adult signals are shown as pseudocolor overlays on the reference
whole-animal images. Bioluminescence intensity is presented
in analog-to-digital units (ADUs) of the camera according to
scale at left of each image in all figures.

showed expression in the appendages, but many neonatal
CMV::luc mice (25%) showed a single bright spot centered dorsally on the head (Fig. 2A and Fig. 3A). This spot
was not observed in any fos::luc mouse. The eyes of about
one half of the adult CMV::luc mice also had detectable
expression (Fig. 2C), but fos::luc mice and CMV::luc
neonates did not (Fig. 2A,2B,2D). Furthermore, CMV::luc
mice produced abdominal signals visible through their
fur (Fig. 2C).
Live mice
To test whether luciferase patterns would be different
between overdosed and non-anesthetized freely-moving
mice, two neonates were injected with luciferin and
imaged continuously. These neonates appeared like overdosed mice. (Compare Fig. 2 and 3.) Therefore, very
young live mice imaged by either method reveal similar
gene expression patterns.

The pattern of expression in live anesthetized adult mice
(5 CMV::luc, 2 fos::luc, Fig. 4A) was not obviously different from signals in mice given an overdose and imaged
immediately. Again, highest expression was in the paws,
tail, ears, and nose. Both transgenic mice showed normal
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Table 1: Comparing bioluminescence intensity in whole body of transgenic mice. Maximum intensity (in ADUs) of mice overdosed with
Nembutal. SD: standard deviation. N: number imaged.

Group

Mean

SD

N

CMV::luc neonates
Fos::luc neonates
CMV::luc adults
Fos::luc adults

6843.4
2272.0
316.8
227.0

4134
1747
240
199

23
22
23
23

circadian behavior (Fig. 4B), indicating that their circadian systems were intact. The phase of running-wheel
activity was set by the light/dark (LD) cycle where they
were maintained before being moved to constant darkness (DD), indicating that they could entrain to the LD
cycle. Furthermore, their behavioral activity was organized into circadian rhythms that are typical of mice in DD.
Additional experiments to determine the average period
of these free-running rhythms are underway.
To examine any effects on signal intensity, five anesthetized CMV::luc adult mice were compared with 13 others
given an overdose and imaged during the same phases of
the LD cycle as the anesthetized mice, between 2 and 14
hours after light onset. Although the same areas were visible in both groups, the maximum signal was on average
2.3-fold higher in the anesthetized mice but was not significantly different by ANOVA and Scheffe posthoc test.
Similarly, two fos::luc mice which were anesthetized and
imaged were on average 2.2-fold brighter than overdosed
fos::luc mice, but were not significantly different.
Hairless mice
Both original transgenic lines were crossed with hairless
albino mice to increase any bioluminescence signals
through the skin that originate from deeper structures.
The overdosed hairless CMV::luc mice (Hr-CMV) showed
luciferase expression in several body regions with clearly
detectable signal in the joints of the paws, tail vertebrae,
and claws that was not visible in the CMV::luc or fos::luc
mice (Fig. 5 and Fig. 2C,2D). Some signal from the dorsal
and ventral abdomen of the Hr-CMV mice may have been
obscured in the haired mice (Fig. 2C and Fig. 5). Light
emanated from the ear canals of the Hr-CMV mice (Fig.
5), possibly from the tympanum, and from the dorsal cranial spot that may be equivalent to the one centered on
the head of CMV::luc neonates (Fig. 2A and Fig. 3A).

Logarithmic scaling of intensity proved to be an effective
way to reveal fine details including the dark areas that
obscured light from deeper areas (Fig. 5). The areas that
were visible by eye using any scaling of the images from
21 overdosed Hr-CMV mice, according to prevalence,

were dorsal abdomen (62%), skeletal muscles (43%), tip
of nose (33%), ear canals (33%), ventral abdomen
(29%), vertebrae of tail (29%), dorsal cranium (20%),
eyes (20%), joints of paws (19%), claws (19%), bottom of
paws (19%), top of paws (10%), and gonads (10%).
To identify internal organs that express the CMV::luc
transgene, both CMV::luc and Hr-CMV mice were dissected 20 minutes after luciferin injection (Fig. 6). The
pancreas was the brightest organ and abdominal muscles
had weaker expression. To confirm the source of the frequent bright signal in the dorsal abdomen, we removed
the pancreas and examined it with a 10× Neofluar lens
(Zeiss) attached to the camera (data not shown). The pancreas showed a diffuse signal throughout its extent, and
because of light scatter, tissue sections deemed necessary
to identify expressing cell types.
An additional five Hr-CMV mice were placed in DD to
monitor circadian rhythms in wheel-running activity. Like
the CMV::luc and fos::luc mice, they also showed normal
circadian rhythms in wheel-running during 14 weeks in
DD, and they were anesthetized and imaged up to four
times each. The spatial patterns of these mice were indistinguishable from those of overdosed Hr-CMV mice, and
efforts are continuing to test for any circadian modulation
of bioluminescence.
Three Hr-fos mice were overdosed and imaged. Signals
were not as distinct as in the Hr-CMV mice, but all three
had expression in the paws and nose. One also expressed
the transgene in the eye, and one expressed in the gonads
and tail, although without the distinct banding pattern of
Hr-CMV tails that corresponds with the vertebrae.

Discussion
Imaging luciferase reporter genes in intact animals enabled observations to be made in a physiologically relevant
state without altered promoter control that can occur in
vitro where cells are in artificial environments and are
often dividing faster than in the animal. Because the
anesthetized and overdosed mice showed similar high
expression in the extremities and ears, this shared pattern
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Figure 3
Imaging
without anesthesia
Imaging without anesthesia. Expression in a non-anesthetized CMV::luc neonate (postnatal day 1). (A) Frequently
observed dorsal cranial spot (arrow). (B) Series of consecutive 1-minute exposures of the same mouse showed the persistence of the signal and a similar expression pattern to that
of overdosed neonates.
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Figuremice
Common
dosed
4 gene expression patterns in anesthetized and overCommon gene expression patterns in anesthetized
and overdosed mice. (A) Adult CMV::luc mouse imaged
while under pentobarbital anesthesia lasting one to four
hours. Expression was not obviously different from mice
given an overdose. Expression shown as an overlay on a reference image. (B) Mice recovered within an hour and produced circadian rhythms in wheel running activity in constant
darkness. Corresponding phase of previous light/dark cycle
shown below. The rhythms in wheel-running activity were
typical of mice maintained in darkness with a period less than
24 hours. Open boxes: when mouse was out of cage for
imaging. Arrows: one daily activity onset. The data was double-plotted (48 hours across) so that circadian rhythms can
be easily followed.
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Figure 5 patterns in Hr-CMV mice
Expression
Expression patterns in Hr-CMV mice. When crossed
with albino hairless mice, the transgenic mice showed substantially less signal in the skin than the haired transgenic
mice and internal structures were visible. (A) Reference
image of an overdosed adult Hr-CMV mouse. (B) Linear scaling of intensity showed detail of the brightest areas, and (C)
logarithmic scale revealed subtle differences in expression in
the ear canal, joints, and muscle in the same image. (D) Reference image of a second adult Hr-CMV mouse taken with f/
1.2 lens and +4 close-up filter (Promaster), (E) linear scale,
and (F) logarithmic scale of same image. Highest signal was
from the tail (B), internal organs (E), some skeletal muscles
(B), ear canals (C and F), claws (F), skull (B and E), joints
(C) and the underside of the paws (C and F). Note that
some dark, non-expressing structures that obscure background light are visible (C and F, black arrows).

was not due to effects from loss of heart beat, breathing or
body temperature. Furthermore, freely-moving mice had
very similar expression patterns to those of overdosed or
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Figure 6 expressed in pancreas and only a few other areas
CMV::luc
CMV::luc expressed in pancreas and only a few other
areas. (A) Reference image of dissected adult CMV::luc
mouse with four areas labeled. (B) Expression from the same
mouse. (C) Dissection of Hr-CMV mouse. Shown is an overlay of the bioluminescence image on the reference image to
identify brightest tissues. Pancreas (P) revealed high expression and muscle tissue (M) showed weak signal, but heart
(H), liver (L), spleen (S), and intestine (I) did not.

anesthetized mice and may be more useful in some imaging experiments that require behavioral assays, although
these experiments were limited to young neonates that
move little. Repeated injections did not influence signals
from the anesthetized mice, indicating that they can be
sampled repeatedly.
CMV versus c-fos
CMV::luc and fos::luc neonates showed similar overall
bioluminescence patterns that were also like those of
freely-moving non-anesthetized neonates. The high
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peripheral expression in both transgenic lines may be due
to elevated skin cell division rates in the tail, ears, and
paws [23]. Fos::luc mice were previously reported to have
high expression in the skin [14], and both the CMV-IE1
and c-fos promoters are active in dividing cells [24,25]
Whether the observed eye signal originated in the retina
and why it was not detected in the fos::luc mice needs to
be addressed.
Why the CMV::luc neonates and the Hr-CMV mice exhibited the dorsal cranial spot is also not yet known. The ventricular and sub-ventricular brain areas are readily infected
by mouse CMV during development [26], and human
CMV reactivation from a latent state depends on IE-1
induction [27,28]. Human CMV infects neurons, glial
cells, endothelial cells [29,30]. The CMV::luc and Hr-CMV
mice may provide insight into gene regulatory factors
responsible for viral infection throughout the body.
It was initially expected that the two transgenes (CMV::luc
and fos::luc), which were derived from different
immediate-early genes, would display distinctly different
expression patterns, although the two do have some common gene regulatory elements. The 5' upstream sequence
(5' US) of c-fos contains a promoter controlled by cAMP
or Ca2+ signaling through a cAMP response element
(CRE), mitogen-activated protein kinases that respond to
growth hormones, or a stress-signaling pathway dependent on STATs (signal transducers and activators of
transcription) [31]. It is also induced early in G1 during
the cell cycle [24].
Similarly, the human CMV 5'US contains a powerful promoter and enhancer that responds through a wide range
of signaling pathways and, like c-fos, also responds
through its multiple CREs [19,20,32]. It is repressed in
some tissues, such as liver, and is reactivated by signaling
pathways acting through NF-kappaB, a transcription factor that mediates inflammation and stress signals [33,34].
A recent study has shown that the CMV 5'US also
responds to membrane depolarization in neurons [22],
and so, like c-fos, could be a marker for neural activity in
the nervous system of CMV::luc mice. Differences in
expression pattern and intensity could be attributed to the
different combinations and types of gene regulatory
elements of the transgenes. Likewise, the common expression in the extremities could be the result of cell turnover
in these tissues to which both transgenes should respond.
Previously, high expression detected in the skin of the
fos::luc mice was tentatively attributed to keratin formation [14]. The lower skin expression in Hr-CMV versus
CMV::luc mice was perhaps due to loss of hair follicles,
pigmentation, or other effects from the albino and hairless mutations.
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The insertion of a transgene can disrupt important genes
involved in behavior. Locomotor activity was used to
detect possible behavioral effects or disruption of the circadian system, although imaging of hypothalamic explant
cultures from the fos::luc and CMV::luc mice has shown
circadian rhythms in transgene expression [14,35], so it
was unlikely that the mice had major mutations of the circadian system. Both transgenic mice provided circadian
rhythms in wheel-running activity and they could entrain
to light/dark cycles. Although a more complete analysis of
their circadian properties will be presented elsewhere,
these first measurements of any behavior in fos::luc or
CMV::luc mice indicate that they can be studied at both
the cell and organism levels. Clearly, the photoreceptors
in the eyes that project to the circadian pacemaker in the
hypothalamic suprachiasmatic nucleus are functional in
these mice, and the pacemaker's regulation of circadian
rhythms in the whole animal persists [36].
Hairless mice
Although, the Hr-fos mice showed less light from internal
structures than the Hr-CMV mice, signal in the extremities
of Hr-fos mice was visible as reported previously in
fos::luc mice [4]. These results are consistent with the
known transient expression of c-fos [15] and suggest that
Hr-fos mice could be useful for detecting induction above
these low baseline signals following a sufficiently strong
stimulus.

Previously, luciferase bioluminescence has been examined in nude BALB/c mice [9], but these are athymic and
lack T-cells, which could alter transgene expression
patterns. Nevertheless, the nude mouse study showed the
time-course of the luciferase signal after luciferin injection
and maximal signals were reached about 20 minutes after
injection, the time used in this study. Unlike nude mice,
Hr-CMV mice are not immunocompromised and therefore require no special housing. Also, Hr-CMV showed no
abnormal behavior and had typical circadian running
wheel rhythms.
Because 62% of the Hr-CMV mice examined had a bright
dorsal abdominal area and the pancreas was the brightest
organ of Hr-CMV and CMV::luc mice dissected immediately after overdosing, we interpret this light as high gene
expression in the pancreas. When the pancreas was
removed, it bioluminesced throughout its length, and
additional cellular studies will be needed to explore
exactly where the light originated. The NF-kappaB pathway of pancreatic cells mediates some responses to cholecystokinin [37], suggesting that direct induction of the
CMV::luc transgene by NF-kappaB may generate the pancreas signal. Although one early report of transgenic mice
did not detect high expression in the pancreas from a
transgene regulated by the human CMV IE-1 enhancer
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and promoter [38], later studies clearly showed high
expression in the pancreas using similar CMV IE-1 constructs [39–43]. Therefore, it is likely that the pancreas signal of Hr-CMV and CMV::luc mice reflects normal
pancreas function. The Hr-CMV mice could be useful in a
research model for pancreatic cancer studies because of
the activation of CMV IE-1 during cell division.
Although heart, kidney, liver, and spleen of Hr-CMV mice
were silent in images, tissue harvested from these organs
of CMV::luc mice have shown luciferase expression after
cell lysis and total luciferase assays [14]. It has been
argued that hemoglobin in "dark" organs such as the
spleen and heart may absorb luciferase bioluminescence
and limit imaging of gene expression [44]. However, this
quenching should enable better detection of the nearby
pancreas signal in Hr-CMV mice.
Imaging considerations
Deep structures of hairless mice may be better imaged
through luciferase than GFP based methods because scattering of light only affects the emission from the luciferase
reaction and not the energy needed for excitation, whereas
GFP excitation requires penetration of excitation light to
the tissue of interest [45]. Light scatter is likely a greater
limitation on imaging than signal intensity. As shown in
this study, signal intensity from luciferase can extend over
several orders of magnitude.

Not surprisingly, signals from bioluminescence can be
best exploited by capturing images with cameras that have
a comparably large dynamic range, particularly ones with
a 16-bit range per pixel. One drawback of the color cameras used by many researchers when imaging GFP is that
they are usually limited to only 8 bits for each of the three
color channels, providing a dynamic range only slightly
better than what the human eye can see when the optical
system is ideally arranged to provide maximal distribution of intensities. In contrast, a 16-bit camera, such as the
liquid nitrogen-cooled CCD camera used here, enables
both the very dim and very bright areas of images to be
imaged simultaneously, as shown by logarithmic scaling
in Fig. 6. Unfortunately, many researchers do not make
full use of camera imaging capabilities and chose to create
images that only provide information with the very limited range of about 100 gray levels used in printing or
viewing by the human eye [46].
Although the spatial pattern of bioluminescence could
conceivably be influenced by the distribution of luciferin,
two points suggests that it would not have a major role
here. First, images of luciferin autofluorescence showed a
diffuse distribution in the brain rather than a signal
restricted to the capillaries. Although these images were
captured 75 minutes after luciferin injection, much longer
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than the time allowed before whole-animal imaging, they
do suggest that luciferin diffuses into the brain. This result
does not show, however, that the luciferin levels are distributed evenly. Nevertheless, luciferin concentrations
could be saturating even at low concentrations in many
areas because release of oxyluciferin from luciferase is
rate-limiting [47,48]. Second, particular differences in
expression between CMV::luc and fos::luc mice (the
dorsal cranial spot and eye signal) also suggest that luciferin levels did not dictate expression patterns. Furthermore, other researchers have addressed this issue and
concluded that luciferin concentration did not limit their
images of bioluminescence in mice [9].
According to the small molecular weight of firefly luciferase, 62 kDa [49] and rough estimates of time required
for transcription and translation, images collected during
the first 10-minutes after an overdose should adequately
reflect luciferase made up to the time of imaging, and
shorter exposures would provide even more conservative
assays of expression. Previous results with fos::luc hypothalamic cell cultures showed that about 4.6 hours is
required for bioluminescence to reach half its maximum
following cell depolarization at 36°C [14]. One outcome
of these results is that imaging of overdosed mice must be
performed as soon after an overdose as possible. Incidentally, the last three images of Fig. 1 may include signal
from expression induced by the procedure, because these
images were taken in series, but this did not seem to have
a large effect on expression patterns.
Finally, the cause of the approximately 2-fold decline in
signal immediately after an overdose is not known.
Although it could be due to a drop in oxygen availability,
many factors may be involved. This reduced signal should
be weighed against loss of spatial resolution in live mice
due to breathing and other spontaneous movements. We
have shown that overdosed mice can provide detailed
images particularly after logarithmic scaling, as in HrCMV mice (Fig. 5), which is useful for screening expression across the animal in fine detail. Because signal
strength of overdosed mice was more than adequate for
quantitative measurements, the signal loss does not compromise measurements. The overdose does not alter the
signal pattern in mice because the same body areas were
visible as in live mice, which suggests that overdosed mice
are practical for assaying the distribution of gene expression. Also, mice often need to be dissected immediately
after an overdose to identify the source of the signal as
shown here with CMV::luc mice. It is important, however,
not to make numerical comparisons between live and
overdosed mice when correlating luciferase intensity with
absolute levels of gene induction.
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The bioluminescent mouse models characterized here
could serve as important tools for biomedical research.
Through this technique, gene expression can be followed
in the same animal, and faint signals can be tracked in vivo
simultaneously with much brighter signals from neighboring tissue [9–11]. CMV IE-1 expression correlates with
known sites of human CMV infection [30], and IE-1
expression is required for CMV reactivation [27]. Consequently, CMV::luc mice could be valuable for imaging
processes responsible for viral infection [27,28]. This
study joins others in describing how to determine the
extent of gene expression spatially and temporally in
intact animals.

Conclusions
Adult fos::luc and CMV::luc transgenic mice showed luciferase expression in the tail, paws, ears, and nose, suggesting similar control of the two immediate-early gene
upstream sequences used in creating these mouse lines. In
contrast, distinct differences between the two lines were
demonstrated by additional expression in the dorsal cranium and eyes in the CMV::luc mice. Neonates of both
lines had higher expression than the adults, which likely
reflects increased immediate-early gene expression during
development. Both lines continued to show expression in
the appendages after mice were crossed with a hairless
albino mouse (HRS/J). The hairless CMV::luc mice also
provided views of internal structures including bones of
the tail and paw, pancreas, and skeletal muscles. Microscopic imaging of luciferin autofluorescence in brain
slices, showed that this luciferase substrate diffuses into
brain tissue following intraperitoneal injection suggesting, along with the imaging results, that it spreads readily
throughout the body. Also, imaging results were not obviously altered by anesthetics used to sedate and immobilize the mice during imaging, although overdosed mice
showed an overall decline in signal. Finally, both lines of
mice displayed circadian locomotor rhythms that
entrained to daily light/dark cycles and persisted following repeated imaging sessions.

Methods
Animals
Transgenic CMV::luc and fos::luc (Tg(Fos::luc)1Rnd, Jackson Laboratories, Bay Harbor, ME) mice Mus musculus
[14] were bred and maintained on a 12:12 hour light/dark
cycle in the Animal Care Facility at Bowling Green State
University, Bowling Green, OH. Animals received food
and water ad libidum in a temperature controlled environment. Light onset for one room was at 9 pm eastern standard time and 7 am for a second room. CMV::luc and
fos::luc mice were crossed with male HRS/J hr/hr mice
(Jackson Laboratories) to create two new lines. Standard
tail clip assays were used to verify luciferase expression in
the progeny [14]. These mice were then further crossed to
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produce mice that were homozygous for the albino and
hairless mutations and either homozygous or hemizygous
for one of the two transgenes (Hr-CMV and Hr-fos). Animal procedures were approved by the University's animal
care committee and met National Institutes of Health
guidelines. All efforts were made to minimize animal
discomfort.
Imaging luciferin fluorescence
Adult CMV::luc mice were injected i.p. with 0.1 ml
sodium salt of luciferin (Molecular Probes, Eugene, OR)
at 10 mM in phosphate buffered saline (PBS). The time
between luciferin injection and imaging was varied from
10 to 75 minutes. The mice were overdosed with sodium
pentobarbital (Nembutal, 0.1 ml, i.p.) and decapitated.
Most mice were exposed briefly to isofluorane vapors to
temporarily anesthetize the mice before luciferin and
Nembutal injections. Brains were removed, sectioned 200
µm-thick, and immediately viewed with an Axiophot epifluorescence microscope (Zeiss, Thornwood, NY)
equipped with a mercury lamp, MicroMax cooled-CCD
camera (Roper Scientific, Tucson, AZ), and DAPI and FITC
filters to image luciferin autofluorescnce. Pixel intensity
was measured with MetaMorph software (Universal Imaging, Downingtown, PA).
Transgenic neonate and adult imaging
Neonates (0–10 days postnatal), juveniles (21 days-2
months), and adults (2–8 months) of both sexes from all
four transgenic mouse lines (CMV::luc, fos::luc, Hr-CMV,
and Hr-fos) were examined at hours distributed evenly
across the 24-hour day. The sodium salt of luciferin was
administrated by intraperitoneal (i.p.) injection (0.1 ml,
10 mM in PBS). After 20 minutes, mice were euthanized
with an overdose of Nembutal (0.1 ml, i.p.). Isofluorane
was given before injections as when examining autofluorescence. To image internal organs, mice were injected
with luciferin, overdosed, and quickly dissected. Particular tissues, skin and pancreas, were removed and imaged
briefly in isolation.

Mice, intact or dissected, were imaged with a Nikkor lens
(f/1.2 or f/1.8) attached to a liquid nitrogen-cooled CCD
camera containing a back-thinned, back-illuminated 512
× 512 pixel 16-bit sensor (Roper Scientific, Tucson, AZ).
Exposures of 10 minutes were used to image bioluminescence. Adults were imaged laterally and neonates were
imaged from a dorsal view to have most of each animal
within the focal range. Background bias current was subtracted from images, cosmic ray event artifacts were
removed with a rank filter and intensity was measured
using V++ software (Roper Scientific, Tucson, AZ).
Live transgenic mice were imaged like overdosed animals
except that 20 minutes after luciferin injection, an
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anesthetizing rather than overdosing Nembutal injection
was administered i.p. (50 mg/kg body weight) to produce
unconsciousness and immobility for 1–4 hours. Neonatal, juvenile, and adult CMV::luc, fos::luc, Hr-CMV, and
Hr-fos mice were imaged for 10-minute exposures at
times throughout the day. Anesthetized mice were placed
in a box on heating pad while imaging. At the end of
experiment, the mouse was observed while it recovered
and then returned to the colony. Non-anesthetized
neonates were imaged with 1-minute exposures.
Locomotor activity
Mice were given at least 3 days in constant darkness (DD)
to adjust to a cage with a running wheel before imaging at
particular phases of the circadian cycle. Mice were moved
in a light-tight container to the imaging room and were
returned to DD after imaging where they recovered completely and began wheel running within a few hours.
Before the next images were taken, the circadian system
was allowed at least 3 days to produce a stable circadian
rhythm after any perturbing effects of the procedure on
the phase of the free-running locomotor rhythm had
passed. Mice were provided with food and water ad
libitum. Mouse running wheels were monitored with magnetic switches, a computer data acquisition system, and
software to continuously count wheel revolutions occurring during 1-minute intervals. Activity counts were plotted and daily activity onsets were used as phase reference
points for circadian rhythms in locomotor activity.
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